NCT02493712View on ClinicalTrials.gov

A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

April 30, 2019

Conditions
Colitis, Ulcerative
Interventions
DRUG

High dose

6 capsules of IBD98-M, twice a day

DRUG

Low dose

4 capsules of IBD98-M

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

Istituto Clinico Humanitas, Milan

Sponsors

Collaborators (1)

inVentiv Health Clinical
All Listed Sponsors
collaborator

inVentiv Health Clinical

OTHER

lead

Holy Stone Healthcare Co., Ltd

INDUSTRY